Ipilimumab/nivolumabNecrotising myositis associated with erythematous rash: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1743卷 / 1期

关键词：

D O I：

10.1007/s40278-019-58817-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：129 / 129

相关论文

共 50 条

[31] CefazolinDelayed allergic reaction manifested as erythematous rash: case report
Reactions Weekly, 2022, 1922 (1) : 167 - 167
[32] Ciclosporin/infliximabLupus with an erythematous scaling rash and hypertension: case report
Reactions Weekly, 2016, 1605 (1) : 48 - 48
[33] Glucagonoma syndrome with severe erythematous rash A rare case report
Wang, Zhen-Xia
Wang, Fei
Zhao, Jian-Guo
MEDICINE, 2019, 98 (37)
[34] Multiple drugsLack of efficacy and erythematous skin rash: case report
Reactions Weekly, 2025, 2056 (1) : 346 - 346
[35] Ipilimumab/nivolumabMyocarditis-myositis overlap syndrome and ocular myositis: case report
Reactions Weekly, 2020, 1827 (1) : 186 - 186
[36] Orbital myositis associated with ipilimumab
Lecouflet, M.
Verschoore, M.
Giard, C.
Gohier, P.
Le Corre, Y.
Milea, D.
Martin, L.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2013, 140 (6-7): : 448 - 451
[37] Ipilimumab/nivolumabDiarrhoea, nausea, rash, hypothyroidism and sarcoidosis: case report
Reactions Weekly, 2017, 1636 (1) : 181 - 181
[38] Ipilimumab/nivolumabBell's palsy, rash and pruritus: case report
Reactions Weekly, 2018, 1684 (1) : 140 - 140
[39] Ipilimumab/nivolumabAppendiceal enlargement, lymphoid hyperplasia and rash: case report
Reactions Weekly, 2019, 1756 (1) : 199 - 199
[40] Ipilimumab/vemurafenibSkin rash, fever and autoimmune hypophysitis: case report
Reactions Weekly, 2017, 1657 (1) : 252 - 252

← 1 2 3 4 5 →